Sarcosine as a potential prostate cancer biomarker and therapeutic target

被引：26

作者：

Baum, Caitlin E. ^{[1
]}

Price, Douglas K. ^{[1
]}

Figg, William D. ^{[1
]}

机构：

[1] NCI, Mol Pharmacol Sect, Canc Res Ctr, NIH, Bethesda, MD 20892 USA

来源：

CANCER BIOLOGY & THERAPY | 2010年 / 9卷 / 05期

关键词：

sarcosine; prostate cancer; biomarker; PSA; metastasis;

D O I：

10.4161/cbt.9.5.11310

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：341 / 342

页数：2

共 7 条

[1]

Bickers B, 2009, ANTICANCER RES, V29, P3289

[2] Prostate cancer imaging [J].

Fuchsjager, M. ;

Shukla-Dave, A. ;

Akin, O. ;

Barentsz, J. ;

Hricak, H. .

ACTA RADIOLOGICA, 2008, 49 (01) :107-120

[3]

HALPERN E, 2006, REV UROL, V8, P29

[4]

LILJA H, 2008, NAT REV CANCER, V8, P11

[5]

SREEKUMAR A, 2009, NAT LETT, V457, P6

[6] Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer [J].

Tomlins, SA ;

Rhodes, DR ;

Perner, S ;

Dhanasekaran, SM ;

Mehra, R ;

Sun, XW ;

Varambally, S ;

Cao, XH ;

Tchinda, J ;

Kuefer, R ;

Lee, C ;

Montie, JE ;

Shah, RB ;

Pienta, KJ ;

Rubin, MA ;

Chinnaiyan, AM .

SCIENCE, 2005, 310 (5748) :644-648

[7] The polycomb group protein EZH2 is involved in progression of prostate cancer [J].

Varambally, S ;

Dhanasekaran, SM ;

Zhou, M ;

Barrette, TR ;

Kumar-Sinha, C ;

Sanda, MG ;

Ghosh, D ;

Pienta, KJ ;

Sewalt, RGAB ;

Otte, AP ;

Rubin, MA ;

Chinnaiyan, AM .

NATURE, 2002, 419 (6907) :624-629

← 1 →